Inspire Investing’s Immunovant IMVT Stock Holding History

Inspire Investing’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$413K	Buy	+12,236	New	+$482K	0.02%	1016

Other funds holding IMVT

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Inspire Investing's IMVT Position: Q3 2026 in Review

Inspire Investing opened a new position in Immunovant (IMVT) in Q3 2026: 12,236 shares worth $413K. The stake represents 0.02% of the portfolio and ranks #1016 among its holdings.

22 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

Inspire Investing held 12,236 shares of Immunovant worth $413K as of Q3 2026.
Immunovant was a new Inspire Investing position in Q3 2026.
Immunovant made up 0.02% of Inspire Investing's portfolio in Q3 2026, its #1016 holding.
22 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.